REACH-DMD study
Taiho’s Investigational DMD Therapy Misses Primary Endpoint in Phase 3 Trial
Taiho; Duchenne muscular dystrophy; DMD; pizuglanstat; TAS-205; Phase 3 trial; clinical trial failure; REACH-DMD study; Otsuka Holdings
Actionable Insights Powered by AI
Taiho; Duchenne muscular dystrophy; DMD; pizuglanstat; TAS-205; Phase 3 trial; clinical trial failure; REACH-DMD study; Otsuka Holdings